4//SEC Filing
Downs Christopher 4
Accession 0001683168-20-002862
CIK 0001729427other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:11 PM ET
Size
4.9 KB
Accession
0001683168-20-002862
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-24$2.04/sh+142,000$289,680→ 142,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001705978
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:11 PM ET
- Size
- 4.9 KB